Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2000;76:555-558; doi:10.1136/pmj.76.899.555
Copyright © 2000 The Fellowship of Postgraduate Medicine.
Postgrad Med J 2000;76:555-558 ( September )

Review

Difficulties in diagnosing and treating depression in the terminally ill cancer patient Mari Lloyd-Williams

Leicestershire Hospice, Groby Road, Leicester LE3 9QE, UK

Correspondence to: Dr Lloyd-Williams

Submitted 26 January 1999; Accepted 7 December 1999

It is estimated that for a quarter of all patients with advanced metastatic cancer, depression will be significant symptom. However up to 80% of the psychological and psychiatric morbidity which develops in cancer patients goes unrecognised and untreated. One of the main difficulties in establishing a diagnosis of an illness where there are no biological markers, physical signs, or diagnostics tests is deciding what can be called "appropriate sadness" as patients approach the end of life and what is a depressive illness.
Criteria for diagnosing depression are discussed together with reasons why established screening tools used in other populations may not be appropriate to screen for depression in terminally ill patients. The use of antidepressants and the role of cognitive therapies are also discussed. For effective treatment of a depressive illness, treatment with antidepressant medication needs to be initiated sooner rather than later and patients may need close supervision to ensure compliance. The awareness of depression, the identification of symptoms, and the initiation of treatment is essential if patients are to be offered optimum palliation of psychological as well as physical symptoms.


Key points

  • Lack of awareness of depression in patients with advanced metastatic cancer.
  • Difficulty in distinguishing between sadness and depression leads to large number of patients not being treated.
  • Antidepressants are prescribed at low doses and are started too late for a therapeutic effect to be obtained.




Keywords: depression; terminal illness; screening


© 2000 by The Fellowship of Postgraduate Medicine

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Lydiatt, W. M., Denman, D., McNeilly, D. P., Puumula, S. E., Burke, W. J. (2008). A Randomized, Placebo-Controlled Trial of Citalopram for the Prevention of Major Depression During Treatment for Head and Neck Cancer. Arch Otolaryngol Head Neck Surg 134: 528-535 [Abstract] [Full Text]  
  • Miller, K. E., Adams, S. M., Miller, M. M. (2006). Antidepressant medication use in palliative care. AM J HOSP PALLIAT CARE 23: 127-133 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.